NERON AI is a Toronto-based neurotechnology company making brain performance measurable, trainable, and trackable in real-world activity. Its platform measures Neuromotor Control — how the brain and body coordinate — across performance, recovery, safety, and aging. A $93B industry tracks the body — heart rate, sleep, glucose — but not the organ driving it. There is no standard for how the brain performs in real-world conditions. NERON is building that standard. The need is universal. From seniors maintaining independence to athletes under pressure to workers in safety-critical roles, individuals require a baseline. Until now, that baseline has not existed at scale. NERON’s platform is a closed loop: Measure. Train. Progress. NERON Dynamics™ delivers a validated, tablet-based assessment generating a Brain Signature™ — a visual representation of neuromotor performance scored 1–100 across five contextual zones. No diagnosis. No labels. NERON Connect™ delivers adaptive neuromotor training calibrated to each Brain Signature, pushing function beyond current thresholds. NERON Intelligence™ (in development) is the predictive AI layer, building longitudinal trajectories and enabling comparison to neurological conditions. Grounded in 20+ years of peer-reviewed research at York University and validated with Defence Research and Development Canada, NERON has collected 8,000+ Brain Signatures — a proprietary dataset that compounds with use. Three forces define the opportunity: global aging, mature AI infrastructure, and no standard for real-world brain performance. NERON targets a $70B–$130B market across longevity, performance, and recovery. NERON is a measurement technology, not a medical device, enabling rapid deployment across clinical, commercial, and performance environments. Active discussions span defence, enterprise healthcare, and national networks. Within five years, Brain Signature histories will be as familiar as heart-rate charts. Your Brain’s Vital Sign.